Ketamine Completed Phase 4 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00419003Research Study for Major Depressive Disorder: Investigation of Glutamate Medications